{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:13:49Z","timestamp":1790622829742,"version":"4.1.0"},"reference-count":26,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"unspecified","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2021,11,1]]},"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To estimate the population prevalence and treatable burden of severe aortic stenosis (AS) in the UK.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We adapted a contemporary model of the population profile of symptomatic and asymptomatic severe AS in Europe and North America to estimate the number of people aged \u226555 years in the UK who might benefit from surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>With a point prevalence of 1.48%, we estimate that 291\u2009448 men and women aged \u226555 years in the UK had severe AS in 2019. Of these, 68.3% (199\u2009059, 95%\u2009CI 1\u200977\u2009201 to 221\u2009355 people) would have been symptomatic and, therefore, more readily treated according to their surgical risk profile; the remaining 31.7% of cases (92\u2009389, 95%\u2009CI 70\u2009093 to 144\u2009247) being asymptomatic. Based on historical patterns of intervention, 58.4% (116\u2009251, 95%\u2009CI 106\u2009895 to 1\u200925\u2009606) of the 199\u2009059 symptomatic cases would qualify for SAVR, with 7208 (95% CI 7091 to 7234) being assessed as being in a high, preoperative surgical risk category. Among the remaining 41.6% (82\u2009809, 95%\u2009CI 73\u2009453 to 92\u2009164) of cases potentially unsuitable for SAVR, an estimated 61.7% (51\u2009093, 95%\u2009CI 34\u2009780 to 67\u2009655) might be suitable for TAVI. We estimate that 172\u2009859 out of 291\u2009448 prevalent cases of severe AS (59.3%) will subsequently die within 5\u2009years without proactive management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These data suggest a high burden of severe AS in the UK requiring surgical or transcatheter intervention that challenges the ongoing capacity of the National Health Service to meet the needs of those affected.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/openhrt-2021-001783","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T06:35:55Z","timestamp":1643178955000},"page":"e001783","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":50,"title":["Uncovering the treatable burden of severe aortic stenosis in the UK"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6800-7119","authenticated-orcid":false,"given":"Geoffrey A","family":"Strange","sequence":"first","affiliation":[{"name":"School of Medicine, University of Notre Dame, Freemantle, Western Australia, Australia"},{"name":"Department of Cardiology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9032-8998","authenticated-orcid":false,"given":"Simon","family":"Stewart","sequence":"additional","affiliation":[{"name":"Centre for Cardiopulmonary Health, Torrens University Australia, Adelaide, South Australia, Australia"},{"name":"School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9651-7829","authenticated-orcid":false,"given":"Nick","family":"Curzen","sequence":"additional","affiliation":[{"name":"Consultant Cardiologist, Faculty of Medicine, University of Southampton & Wessex Cardiothoracic Unit, University Hospital Southampton NHS Trust, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7775-1900","authenticated-orcid":false,"given":"Simon","family":"Ray","sequence":"additional","affiliation":[{"name":"Consultant Cardiologist, Manchester University Hospitals Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Kendall","sequence":"additional","affiliation":[{"name":"President, Society of Cardiothoracic Surgeons of Great Britain & Ireland, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Braidley","sequence":"additional","affiliation":[{"name":"Consultant Cardiothoracic Surgeon, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Pearce","sequence":"additional","affiliation":[{"name":"Consultant Cardiac Scientist, Manchester University NHS Foundation Trust, Manchester, Greater Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Pessotto","sequence":"additional","affiliation":[{"name":"Consultant Cardiac Surgeon, Royal Infirmary, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4492-1103","authenticated-orcid":false,"given":"David","family":"Playford","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Notre Dame, Freemantle, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huon H","family":"Gray","sequence":"additional","affiliation":[{"name":"Emeritus National Clinical Director for Heart Disease, NHS England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,1,26]]},"reference":[{"key":"2025081710224325000_9.1.e001783.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69208-8"},{"key":"2025081710224325000_9.1.e001783.2","first-page":"1","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"00","author":"Beyersdorf","year":"2021","journal-title":"Eur Heart J"},{"key":"2025081710224325000_9.1.e001783.3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw229"},{"key":"2025081710224325000_9.1.e001783.4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fcvm.2018.00112","article-title":"Predicting disease progression and mortality in aortic stenosis: a systematic review of imaging biomarkers and meta-analysis","volume":"5","author":"Nchimi","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"key":"2025081710224325000_9.1.e001783.5","article-title":"Incident aortic stenosis in 49 449 men and 42 229 women investigated with routine echocardiography","volume":"8","author":"Stewart","year":"2021","journal-title":"Heart"},{"key":"2025081710224325000_9.1.e001783.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.08.004"},{"key":"2025081710224325000_9.1.e001783.7","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-021-06843-0","article-title":"Uncovering the treatable burden of severe aortic stenosis in Australia: current and future projections within an ageing population","volume":"21","author":"Strange","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"2025081710224325000_9.1.e001783.8","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2019-314940"},{"key":"2025081710224325000_9.1.e001783.9","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jamacardio.2018.3152","article-title":"Outcomes of patients with asymptomatic aortic stenosis followed up in heart valve clinics","volume":"3","author":"Lancellotti","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2025081710224325000_9.1.e001783.10","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2020-317323"},{"key":"2025081710224325000_9.1.e001783.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2020.04.024"},{"key":"2025081710224325000_9.1.e001783.12","unstructured":"National Health Service , 2021. Available: https:\/\/www.longtermplan.nhs.uk [Accessed May 2021]."},{"key":"2025081710224325000_9.1.e001783.13","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001547","article-title":"'Valve for life': tackling the deficit in transcatheter treatment of heart valve disease in the UK","volume":"8","author":"Ali","year":"2021","journal-title":"Open Heart"},{"key":"2025081710224325000_9.1.e001783.14","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2019-315606"},{"key":"2025081710224325000_9.1.e001783.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.05.015"},{"key":"2025081710224325000_9.1.e001783.16","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy107"},{"key":"2025081710224325000_9.1.e001783.17","doi-asserted-by":"publisher","DOI":"10.1136\/heart.89.1.49"},{"key":"2025081710224325000_9.1.e001783.18","unstructured":"Population estimates for the UK, England and Wales, Scotland and Northern Ireland - Office for National Statistics (ons.gov.uk)."},{"key":"2025081710224325000_9.1.e001783.19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa070"},{"key":"2025081710224325000_9.1.e001783.20","doi-asserted-by":"crossref","first-page":"877","DOI":"10.4244\/EIJ-D-18-00460","article-title":"One-Year outcomes of patients with severe aortic stenosis and an STS PROM of less than three percent in the SURTAVI trial","volume":"14","author":"Serruys","year":"2018","journal-title":"EuroIntervention"},{"key":"2025081710224325000_9.1.e001783.21","article-title":"Indirect impact of the COVID-19 pandemic on activity and outcomes of transcatheter and surgical treatment of aortic stenosis in England","volume":"14","author":"Martin","year":"2021","journal-title":"Circulation"},{"key":"2025081710224325000_9.1.e001783.22","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2017-312487"},{"key":"2025081710224325000_9.1.e001783.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2003.12.002"},{"key":"2025081710224325000_9.1.e001783.24","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011036","article-title":"Characteristics and prognosis of patients with moderate aortic stenosis and preserved left ventricular ejection fraction","volume":"8","author":"Delesalle","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2025081710224325000_9.1.e001783.25","unstructured":"Adult Cardiac Surgery (Surgery Audit) . National Institute for cardiovascular outcomes research (NICOR). Available: https:\/\/www.nicor.org.uk\/national-cardiac-audit-programme\/adult-cardiac-surgery-surgery-audit\/ [Accessed Jun 2021]."},{"key":"2025081710224325000_9.1.e001783.26","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-307807"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2021-001783","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T17:22:50Z","timestamp":1755451370000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2021-001783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,26]]},"published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1136\/openhrt-2021-001783"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2021-001783","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}